首页 > 最新文献

Annals of Saudi Medicine最新文献

英文 中文
Trends in colorectal cancer in Iraq over two decades: incidence, mortality, topography and morphology. 二十年来伊拉克结直肠癌的趋势:发病率、死亡率、地形和形态。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-07-01 Epub Date: 2022-08-04 DOI: 10.5144/0256-4947.2022.252
Salih Ibrahem, Hussien Ahmed, Suhair Zangana

Background: Colorectal cancer (CRC) is mainly a disease of the elderly in the Western world, but its characteristics are changing globally. Iraq does not have a well established CRC screening program. Understanding trends of CRC incidence, fatality and the clinical features of CRC patients is vital to the design of effective public health measures; public awareness, screening, diagnosis and treatment strategies to meet the future demands.

Objectives: Determine trends in demography, incidence proportion, mortality, topography (primary tumor site) and morphology (histology) over two decades.

Design: Registry-based study SETTING: Iraqi National Cancer Registry (INCR) database PATIENTS AND METHODS: We collected and analyzed data from CRC patients obtained from the INCR to calculate incidence and mortality proportion per 100 000 population for the period from 2000 to 2019. In addition to estimation, data were examined by anatomic location and morphological type.

Main outcome measures: Change in the incidence and mortality proportion, topography and morphology of CRC over 20 years.

Sample size: 20 880 CRC patients ranging in age from 14-80 years.

Results: The overall (males and females) CRC incidence proportion (CIP) increased from 2.28 to 6.18 per 100 000 population in 2000 and 2019, respectively, with an annual percentage change (APC) of 5.11%. The incidence proportion (IP) of CRC in patients from 20 to <50 years rose from 1.46 in 2000 to 4.36 per 100 000 population in 2019, which is an APC of 5.6%. The IP in patients older than 50 years rose from 12.7 to 40.59 per 100 000 population in 2000 and 2019, respectively, with an APC of 5.98%. The percentage of all CRC cases to all total malignancies in Iraq grew from 3.69% in 2000 to 6.5% in 2019. The CRC mortality proportion increased from 1.25 to 1.77 per 100 000 populations in 2010 and 2019, respectively, reflecting an APC of 3.54%. Anatomically, colon (C18) tumor represented 59.2% and 65.7% in 2000 and 2019, respectively. Rectal (C20) tumors were 37.2% in 2000 down to 31.4% in 2019, while rectosigmoid junction tumor (C19) were 3.6% in 2000 dropping to 2% in 2019.

Conclusions: CRC in Iraq is still a disease of the elderly and is rising in incidence and mortality in all age groups. This necessitates reconsidering health policy regarding CRC; public awareness, screening and management strategies to accommodate for these alarming changes.

Limitations: Data about stages, grades and molecular characterisations are not available in the INCR.

Conflict of interest: None.

背景:结直肠癌(Colorectal cancer, CRC)在西方国家主要是老年人的疾病,但其特征在全球范围内正在发生变化。伊拉克没有完善的CRC筛查项目。了解结直肠癌发病率、病死率的变化趋势和结直肠癌患者的临床特征对制定有效的公共卫生措施至关重要;公众意识,筛查,诊断和治疗策略,以满足未来的需求。目的:确定二十年来人口统计学、发病率、死亡率、地形(原发肿瘤部位)和形态学(组织学)的趋势。设计:基于登记的研究设置:伊拉克国家癌症登记处(INCR)数据库患者和方法:我们收集并分析了从INCR获得的结直肠癌患者的数据,以计算2000年至2019年每10万人中的发病率和死亡率比例。除了估计外,数据还通过解剖位置和形态类型进行了检查。主要观察指标:20年来CRC的发病率和死亡率、地形和形态的变化。样本量:20 880例结直肠癌患者,年龄14-80岁。结果:2000年和2019年,总体(男性和女性)结直肠癌发病率(CIP)分别从每10万人2.28例上升至6.18例,年变化百分比(APC)为5.11%。结论:在伊拉克,结直肠癌仍是老年人的疾病,各年龄组的发病率和死亡率均呈上升趋势。这就需要重新考虑有关CRC的卫生政策;适应这些惊人变化的公众认识、筛选和管理战略。局限性:INCR中没有关于分期、分级和分子特征的数据。利益冲突:无。
{"title":"Trends in colorectal cancer in Iraq over two decades: incidence, mortality, topography and morphology.","authors":"Salih Ibrahem,&nbsp;Hussien Ahmed,&nbsp;Suhair Zangana","doi":"10.5144/0256-4947.2022.252","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.252","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer (CRC) is mainly a disease of the elderly in the Western world, but its characteristics are changing globally. Iraq does not have a well established CRC screening program. Understanding trends of CRC incidence, fatality and the clinical features of CRC patients is vital to the design of effective public health measures; public awareness, screening, diagnosis and treatment strategies to meet the future demands.</p><p><strong>Objectives: </strong>Determine trends in demography, incidence proportion, mortality, topography (primary tumor site) and morphology (histology) over two decades.</p><p><strong>Design: </strong>Registry-based study SETTING: Iraqi National Cancer Registry (INCR) database PATIENTS AND METHODS: We collected and analyzed data from CRC patients obtained from the INCR to calculate incidence and mortality proportion per 100 000 population for the period from 2000 to 2019. In addition to estimation, data were examined by anatomic location and morphological type.</p><p><strong>Main outcome measures: </strong>Change in the incidence and mortality proportion, topography and morphology of CRC over 20 years.</p><p><strong>Sample size: </strong>20 880 CRC patients ranging in age from 14-80 years.</p><p><strong>Results: </strong>The overall (males and females) CRC incidence proportion (CIP) increased from 2.28 to 6.18 per 100 000 population in 2000 and 2019, respectively, with an annual percentage change (APC) of 5.11%. The incidence proportion (IP) of CRC in patients from 20 to <50 years rose from 1.46 in 2000 to 4.36 per 100 000 population in 2019, which is an APC of 5.6%. The IP in patients older than 50 years rose from 12.7 to 40.59 per 100 000 population in 2000 and 2019, respectively, with an APC of 5.98%. The percentage of all CRC cases to all total malignancies in Iraq grew from 3.69% in 2000 to 6.5% in 2019. The CRC mortality proportion increased from 1.25 to 1.77 per 100 000 populations in 2010 and 2019, respectively, reflecting an APC of 3.54%. Anatomically, colon (C18) tumor represented 59.2% and 65.7% in 2000 and 2019, respectively. Rectal (C20) tumors were 37.2% in 2000 down to 31.4% in 2019, while rectosigmoid junction tumor (C19) were 3.6% in 2000 dropping to 2% in 2019.</p><p><strong>Conclusions: </strong>CRC in Iraq is still a disease of the elderly and is rising in incidence and mortality in all age groups. This necessitates reconsidering health policy regarding CRC; public awareness, screening and management strategies to accommodate for these alarming changes.</p><p><strong>Limitations: </strong>Data about stages, grades and molecular characterisations are not available in the INCR.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":" ","pages":"252-261"},"PeriodicalIF":1.6,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5a/04/0256-4947.2022.252.PMC9357297.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40686130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Association between serum vitamin D levels and age in patients with epilepsy: a retrospective study from an epilepsy center in Saudi Arabia. 癫痫患者血清维生素D水平与年龄的关系:来自沙特阿拉伯癫痫中心的回顾性研究
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-07-01 DOI: 10.5144/0256-4947.2022.262
Hussam Mohammed Alhaidari, Fawzi Babtain, Khalid Alqadi, Abdulrahman Bouges, Saleh Baeesa, Youssef A Al-Said

Background: Vitamin D deficiency has been linked to various medical conditions such as bone loss, decreased mineralization, endocrine disorders, and central nervous system disorders, including epilepsy. Vitamin D deficiency is prevalent among patients with epilepsy (PWE). However, the specific association between vitamin D levels and age in PWE is unclear.

Objectives: Identify the relation between vitamin D level and age in PWE and evaluate factors that may play a role in seizure control.

Design: Retrospective analytical medical record review SETTING: Outpatient epilepsy research clinic in Saudi Arabia PATIENTS AND METHODS: Between November 2016 and April 2020, we selected eligible PWE aged older than 14 years whose vita-min D levels were recorded at least once after reviewing 1550 patient electronic files. We analyzed data on serum vitamin D level by age and other factors, vitamin D supplement use, seizure classification, and conducted a multivariate logistic regression to assess associations with seizure control.

Main outcome measures: Relationships between vitamin D levels and age and factors that might affect seizure control.

Sample size: 524 patients RESULTS: The prevalence of low serum vitamin D levels was high (86.8%). The median vitamin D level in all patients was low (38 nmol/L), and was lower in young PWE than in adult PWE (P<.01). Only 146 patients received vitamin D supplements. High vitamin D levels were associated with a 40% seizure reduction.

Conclusion: Vitamin D deficiency is underestimated in PWE in Saudi Arabia, and is more prevalent among young adults and patients on polytherapy than in other PWE. Patients with high vitamin D levels had good seizure control compared with those with low levels. The effect of vitamin D supplements on seizure control should be further investigated in randomized control trials.

Limitations: Retrospective study and no categorization by presence of supplementation.

Conflict of interest: None.

背景:维生素D缺乏与多种疾病有关,如骨质流失、矿化减少、内分泌紊乱和中枢神经系统疾病,包括癫痫。维生素D缺乏症在癫痫患者(PWE)中很普遍。然而,PWE患者维生素D水平与年龄之间的具体关系尚不清楚。目的:确定PWE患者维生素D水平与年龄的关系,并评价可能在癫痫发作控制中起作用的因素。设计:回顾性分析医疗记录回顾设置:沙特阿拉伯癫痫门诊研究诊所患者和方法:2016年11月至2020年4月,在回顾1550例患者电子档案后,我们选择了年龄大于14岁且至少记录一次维生素D水平的合格PWE。我们分析了血清维生素D水平与年龄和其他因素、维生素D补充剂使用、癫痫发作分类的关系,并进行了多因素logistic回归来评估与癫痫发作控制的关系。主要结果测量:维生素D水平与年龄和可能影响癫痫控制的因素之间的关系。结果:血清维生素D水平低的患病率较高(86.8%)。所有患者的维生素D水平中位数较低(38 nmol/L),年轻PWE低于成年PWE(结论:维生素D缺乏症在沙特阿拉伯的PWE中被低估,在年轻人和接受多种治疗的患者中比其他PWE更普遍。与维生素D水平较低的患者相比,维生素D水平高的患者癫痫发作控制较好。维生素D补充剂对癫痫发作控制的作用有待进一步的随机对照试验研究。局限性:回顾性研究,没有根据补充物的存在进行分类。利益冲突:无。
{"title":"Association between serum vitamin D levels and age in patients with epilepsy: a retrospective study from an epilepsy center in Saudi Arabia.","authors":"Hussam Mohammed Alhaidari,&nbsp;Fawzi Babtain,&nbsp;Khalid Alqadi,&nbsp;Abdulrahman Bouges,&nbsp;Saleh Baeesa,&nbsp;Youssef A Al-Said","doi":"10.5144/0256-4947.2022.262","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.262","url":null,"abstract":"<p><strong>Background: </strong>Vitamin D deficiency has been linked to various medical conditions such as bone loss, decreased mineralization, endocrine disorders, and central nervous system disorders, including epilepsy. Vitamin D deficiency is prevalent among patients with epilepsy (PWE). However, the specific association between vitamin D levels and age in PWE is unclear.</p><p><strong>Objectives: </strong>Identify the relation between vitamin D level and age in PWE and evaluate factors that may play a role in seizure control.</p><p><strong>Design: </strong>Retrospective analytical medical record review SETTING: Outpatient epilepsy research clinic in Saudi Arabia PATIENTS AND METHODS: Between November 2016 and April 2020, we selected eligible PWE aged older than 14 years whose vita-min D levels were recorded at least once after reviewing 1550 patient electronic files. We analyzed data on serum vitamin D level by age and other factors, vitamin D supplement use, seizure classification, and conducted a multivariate logistic regression to assess associations with seizure control.</p><p><strong>Main outcome measures: </strong>Relationships between vitamin D levels and age and factors that might affect seizure control.</p><p><strong>Sample size: </strong>524 patients RESULTS: The prevalence of low serum vitamin D levels was high (86.8%). The median vitamin D level in all patients was low (38 nmol/L), and was lower in young PWE than in adult PWE (<i>P</i><.01). Only 146 patients received vitamin D supplements. High vitamin D levels were associated with a 40% seizure reduction.</p><p><strong>Conclusion: </strong>Vitamin D deficiency is underestimated in PWE in Saudi Arabia, and is more prevalent among young adults and patients on polytherapy than in other PWE. Patients with high vitamin D levels had good seizure control compared with those with low levels. The effect of vitamin D supplements on seizure control should be further investigated in randomized control trials.</p><p><strong>Limitations: </strong>Retrospective study and no categorization by presence of supplementation.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 4","pages":"262-268"},"PeriodicalIF":1.6,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5e/33/0256-4947.2022.262.PMC9357294.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9225580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Comparison of nutritional risk status assessment tools in predicting 30-day survival in critically ill COVID-19 pneumonia patients. 营养风险状况评估工具在预测COVID-19肺炎危重患者30天生存中的比较
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-07-01 Epub Date: 2022-08-04 DOI: 10.5144/0256-4947.2022.236
Umut Sabri Kasapoglu, Abdullah Gok, Leman Acun Delen, Ayse Belin Ozer

Background: Few clinical studies have addressed nutritional risk assessment in patients with COVID-19 pneumonia admitted to the intensive care unit (ICU).

Objectives: Assess the nutritional risk status of the critically ill COVID-19 pneumonia patients admitted to the ICU, and compare the nutritional risk screening tools.

Design: Medical record review SETTING: Tertiary critical care unit PATIENTS AND METHODS: We included adult (age >18 years) PCR-confirmed critically ill COVID-19 pneumonia cases admitted to the ICU between August 2020 and September 2021. Scoring systems were used to assess COVID-19 severity and nutritional status (mNUTRIC: modified Nutrition Risk in Critically Ill, NRS2002: Nutritional Risk Screening 2002). The 30-day mortality prediction performance of nutritional scores and survival comparisons between clinical and demographic factors were assessed.

Main outcome measures: Compare the nutrition risk tools SAMPLE SIZE: 281 patients with a mean (SD) age of 64.3 (13.3) years; 143 (50.8%) were 65 years and older.

Results: The mean mNUTRIC score of the cases was 3.81 (1.66) and the mean NRS-2002 score was 3.21 (0.84.), and 101 (35.9%) were at high risk of malnutrition according to the mNUTRIC score and 229 (81.4%) according to the NRS 2002 score. In cases at high risk of malnutrition by the mNUTRIC score there was a greater need for invasive mechanical ventilation, vasopressors, and renal replacement therapy (P<.001 for all comparisons). The mNUTRIC score was superior to the NRS-2002 score in estimating 30-day mortality. In patients who died within 30 days, the mNUTRIC score and NRS-2002 score on the day of hospitalization were significantly higher (P<.001), and the proportion of patients with NRS-2002 score ≥3 and mNUTRIC score ≥5 was significantly higher in the non-surviving group (P<.001). In addition, patients with a high risk of malnutrition had a shorter survival time. The mNUTRIC score was an independent and important prognostic factor for 30-day mortality, and patients with an mNUTRIC score ≥5 had a 6.26-fold risk for 30-day mortality in the multivariate Cox regression.

Conclusion: One third of critical COVID-19 pneumonia cases hospitalized in the ICU due to acute respiratory failure have a high risk of malnutrition, and a high mNUTRIC score is associated with increased mortality.

Limitations: Single center retrospective study.

Conflict of interest: None.

背景:很少有临床研究涉及重症监护病房(ICU)收治的COVID-19肺炎患者的营养风险评估。目的:评估ICU收治的COVID-19肺炎危重患者的营养风险状况,并比较营养风险筛查工具。设计:病历回顾设置:三级重症监护病房患者和方法:我们纳入了2020年8月至2021年9月期间入住ICU的成人(年龄>18岁)pcr确诊的重症COVID-19肺炎病例。使用评分系统评估COVID-19的严重程度和营养状况(mNUTRIC:修订的危重患者营养风险,NRS2002:营养风险筛查2002)。评估营养评分的30天死亡率预测性能以及临床和人口统计学因素之间的生存比较。主要结局指标:比较营养风险工具样本大小:281例患者,平均(SD)年龄64.3(13.3)岁;65岁及以上143例(50.8%)。结果:mNUTRIC评分平均为3.81分(1.66分),NRS-2002评分平均为3.21分(0.84分),其中mNUTRIC评分为营养不良高危人群101例(35.9%),NRS-2002评分为229例(81.4%)。在mNUTRIC评分为营养不良高风险的病例中,更需要有创机械通气、血管加压药物和肾脏替代治疗(ppp)结论:因急性呼吸衰竭住院的重症COVID-19肺炎患者中,有三分之一存在营养不良高风险,且高mNUTRIC评分与死亡率增加相关。局限性:单中心回顾性研究。利益冲突:无。
{"title":"Comparison of nutritional risk status assessment tools in predicting 30-day survival in critically ill COVID-19 pneumonia patients.","authors":"Umut Sabri Kasapoglu,&nbsp;Abdullah Gok,&nbsp;Leman Acun Delen,&nbsp;Ayse Belin Ozer","doi":"10.5144/0256-4947.2022.236","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.236","url":null,"abstract":"<p><strong>Background: </strong>Few clinical studies have addressed nutritional risk assessment in patients with COVID-19 pneumonia admitted to the intensive care unit (ICU).</p><p><strong>Objectives: </strong>Assess the nutritional risk status of the critically ill COVID-19 pneumonia patients admitted to the ICU, and compare the nutritional risk screening tools.</p><p><strong>Design: </strong>Medical record review SETTING: Tertiary critical care unit PATIENTS AND METHODS: We included adult (age >18 years) PCR-confirmed critically ill COVID-19 pneumonia cases admitted to the ICU between August 2020 and September 2021. Scoring systems were used to assess COVID-19 severity and nutritional status (mNUTRIC: modified Nutrition Risk in Critically Ill, NRS2002: Nutritional Risk Screening 2002). The 30-day mortality prediction performance of nutritional scores and survival comparisons between clinical and demographic factors were assessed.</p><p><strong>Main outcome measures: </strong>Compare the nutrition risk tools SAMPLE SIZE: 281 patients with a mean (SD) age of 64.3 (13.3) years; 143 (50.8%) were 65 years and older.</p><p><strong>Results: </strong>The mean mNUTRIC score of the cases was 3.81 (1.66) and the mean NRS-2002 score was 3.21 (0.84.), and 101 (35.9%) were at high risk of malnutrition according to the mNUTRIC score and 229 (81.4%) according to the NRS 2002 score. In cases at high risk of malnutrition by the mNUTRIC score there was a greater need for invasive mechanical ventilation, vasopressors, and renal replacement therapy (<i>P</i><.001 for all comparisons). The mNUTRIC score was superior to the NRS-2002 score in estimating 30-day mortality. In patients who died within 30 days, the mNUTRIC score and NRS-2002 score on the day of hospitalization were significantly higher (<i>P</i><.001), and the proportion of patients with NRS-2002 score ≥3 and mNUTRIC score ≥5 was significantly higher in the non-surviving group (<i>P</i><.001). In addition, patients with a high risk of malnutrition had a shorter survival time. The mNUTRIC score was an independent and important prognostic factor for 30-day mortality, and patients with an mNUTRIC score ≥5 had a 6.26-fold risk for 30-day mortality in the multivariate Cox regression.</p><p><strong>Conclusion: </strong>One third of critical COVID-19 pneumonia cases hospitalized in the ICU due to acute respiratory failure have a high risk of malnutrition, and a high mNUTRIC score is associated with increased mortality.</p><p><strong>Limitations: </strong>Single center retrospective study.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":" ","pages":"236-245"},"PeriodicalIF":1.6,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f4/71/0256-4947.2022.236.PMC9357296.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40685671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Features and diagnostic accuracy of fine needle aspiration cytology of thyroid nodules: retrospective study from Oman. 甲状腺结节细针穿刺细胞学特征及诊断准确性:阿曼回顾性研究。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-07-01 Epub Date: 2022-08-04 DOI: 10.5144/0256-4947.2022.246
Rafie Alhassan, Noor Al Busaidi, Abdul Hakeem Al Rawahi, Hilal Al Musalhi, Ali Al Muqbali, Prakash Shanmugam, Fatma Ali Ramadhan

Background: Fine needle aspiration cytology (FNAC) of the thyroid has been a reliable and cost-effective method for diagnosing thyroid disorders. Since FNAC results are usually operator dependent, there is a compelling need to explore FNAC accuracy among Omanis.

Objective: Describe cytological features of FNAC and assess FNAC accuracy compared to the postsurgical histopathology report.

Design: Retrospective diagnostic accuracy study SETTING: Tertiary care center.

Patients and methods: Our study included adult Omani adult patients with thyroid nodules who underwent FNAC from 2014 to 2017 and had final pathology results for patients who underwent thyroid surgery. The results were classified according to the UK Royal college of Pathologists 'Thy' categories. Accuracy of FNAC was calculated by determining false and true positive and negative results based on histopathology findings.

Main outcome measures: FNAC accuracy (sensitivity and specificity) compared to the postsurgical histopathology.

Sample size: 867 patients with 1359 ultrasound guided FNACs of thyroid nodule; 137 underwent surgery.

Results: The mean age of the 867 patients was 43.7 (13.3) years, with a median of 42 years, and 87.8% were females. Out of 1359 FNACs, 1001 (73.7%) were benign (Thy2), 119 (8.8%) were atypia of undetermined significance or follicular lesion of undetermined significance (Thy3a), 31 (2.3%) were follicular neoplasm or suspicious for a follicular neoplasm (Thy3f), 52 (3.8%) were suspicious for malignancy (Thy4), 55 (4%) were malignant (Thy5), 101 (7.4%) as Unsatisfactory (Thy1). Only 137 patients underwent thyroid surgery, and the FNAC reports were compared with their final histopathology reports. The sensitivity, specificity and total accuracy of FNAC were 80.2%, 98.9% and 89.9%, respectively. The positive and negative predictive values of FNAC were 98.6% and 84.3%, respectively.

Conclusion: Our study findings confirmed that FNAC of the thyroid is a sensitive, specific, and accurate initial tool for the diagnosis of thyroid lesions. Most of the FNACs were benign with a very low malignancy rate. Due to the minimal chance of false negative results and the slow-growing nature of thyroid malignancy, it is important that patients with benign FNAC should have periodic clinical and radiological follow-up.

Limitations: Retrospective design and single-center study, and thyroid nodule size unavailable.

Conflict of interest: None.

背景:甲状腺细针穿刺细胞学(FNAC)已成为诊断甲状腺疾病的一种可靠和经济的方法。由于FNAC结果通常依赖于操作员,因此迫切需要探索阿曼人的FNAC准确性。目的:描述FNAC的细胞学特征,并与术后组织病理学报告比较FNAC的准确性。设计:回顾性诊断准确性研究设置:三级保健中心。患者和方法:我们的研究纳入了2014年至2017年接受FNAC治疗的阿曼成年甲状腺结节患者,并获得了甲状腺手术患者的最终病理结果。研究结果根据英国皇家病理学家学院的Thy分类进行分类。FNAC的准确性是根据组织病理学结果确定假阳性、真阳性和阴性结果来计算的。主要观察指标:FNAC准确性(敏感性和特异性)与术后组织病理学比较。样本量:867例超声引导甲状腺结节FNACs 1359例;137人接受了手术。结果:867例患者平均年龄43.7(13.3)岁,中位年龄42岁,女性占87.8%。在1359例FNACs中,1001例(73.7%)为良性(Thy2), 119例(8.8%)为意义不明的异型或意义不明的滤泡性病变(Thy3a), 31例(2.3%)为滤泡性肿瘤或可疑滤泡性肿瘤(Thy3f), 52例(3.8%)为可疑恶性(Thy4), 55例(4%)为恶性(Thy5), 101例(7.4%)为不满意(Thy1)。只有137名患者接受了甲状腺手术,并将FNAC报告与最终的组织病理学报告进行了比较。FNAC的敏感性为80.2%,特异性为98.9%,总准确度为89.9%。FNAC阳性预测值为98.6%,阴性预测值为84.3%。结论:我们的研究结果证实了甲状腺FNAC是一种敏感、特异、准确的甲状腺病变诊断的初始工具。大多数FNACs为良性,恶性发生率极低。由于假阴性结果的可能性很小,甲状腺恶性肿瘤生长缓慢,因此良性FNAC患者应定期进行临床和放射学随访。局限性:回顾性设计和单中心研究,无法获得甲状腺结节大小。利益冲突:无。
{"title":"Features and diagnostic accuracy of fine needle aspiration cytology of thyroid nodules: retrospective study from Oman.","authors":"Rafie Alhassan,&nbsp;Noor Al Busaidi,&nbsp;Abdul Hakeem Al Rawahi,&nbsp;Hilal Al Musalhi,&nbsp;Ali Al Muqbali,&nbsp;Prakash Shanmugam,&nbsp;Fatma Ali Ramadhan","doi":"10.5144/0256-4947.2022.246","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.246","url":null,"abstract":"<p><strong>Background: </strong>Fine needle aspiration cytology (FNAC) of the thyroid has been a reliable and cost-effective method for diagnosing thyroid disorders. Since FNAC results are usually operator dependent, there is a compelling need to explore FNAC accuracy among Omanis.</p><p><strong>Objective: </strong>Describe cytological features of FNAC and assess FNAC accuracy compared to the postsurgical histopathology report.</p><p><strong>Design: </strong>Retrospective diagnostic accuracy study SETTING: Tertiary care center.</p><p><strong>Patients and methods: </strong>Our study included adult Omani adult patients with thyroid nodules who underwent FNAC from 2014 to 2017 and had final pathology results for patients who underwent thyroid surgery. The results were classified according to the UK Royal college of Pathologists 'Thy' categories. Accuracy of FNAC was calculated by determining false and true positive and negative results based on histopathology findings.</p><p><strong>Main outcome measures: </strong>FNAC accuracy (sensitivity and specificity) compared to the postsurgical histopathology.</p><p><strong>Sample size: </strong>867 patients with 1359 ultrasound guided FNACs of thyroid nodule; 137 underwent surgery.</p><p><strong>Results: </strong>The mean age of the 867 patients was 43.7 (13.3) years, with a median of 42 years, and 87.8% were females. Out of 1359 FNACs, 1001 (73.7%) were benign (Thy2), 119 (8.8%) were atypia of undetermined significance or follicular lesion of undetermined significance (Thy3a), 31 (2.3%) were follicular neoplasm or suspicious for a follicular neoplasm (Thy3f), 52 (3.8%) were suspicious for malignancy (Thy4), 55 (4%) were malignant (Thy5), 101 (7.4%) as Unsatisfactory (Thy1). Only 137 patients underwent thyroid surgery, and the FNAC reports were compared with their final histopathology reports. The sensitivity, specificity and total accuracy of FNAC were 80.2%, 98.9% and 89.9%, respectively. The positive and negative predictive values of FNAC were 98.6% and 84.3%, respectively.</p><p><strong>Conclusion: </strong>Our study findings confirmed that FNAC of the thyroid is a sensitive, specific, and accurate initial tool for the diagnosis of thyroid lesions. Most of the FNACs were benign with a very low malignancy rate. Due to the minimal chance of false negative results and the slow-growing nature of thyroid malignancy, it is important that patients with benign FNAC should have periodic clinical and radiological follow-up.</p><p><strong>Limitations: </strong>Retrospective design and single-center study, and thyroid nodule size unavailable.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":" ","pages":"246-251"},"PeriodicalIF":1.6,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3f/92/0256-4947.2022.246.PMC9357295.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40685669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Outcome after single dose of ChAdOx1 vaccine against SARS-CoV-2 infection at 16 weeks post-vaccination among healthy adults in Saudi Arabia. 沙特阿拉伯健康成人接种单剂ChAdOx1疫苗后16周抗SARS-CoV-2感染的结果
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-07-01 Epub Date: 2022-08-04 DOI: 10.5144/0256-4947.2022.223
Ahlam Alghamdi, Nasser Alsanea, Mohammed Alraey, Mercy Joseph, Mohammed Aboud, Thamer Almangour, Wasaef Alharbi, Hind Alhumidan, Abdalrhman Alanizi, Ahmed Al-Jedai

Background: The rate of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infection and immunogenicity of a single dose of ChAdOx1 vaccine at 16 weeks post-vaccination among young and healthy participants remains unclear in Saudi Arabia.

Objectives: Assess the rate of subsequent infection and immunogenicity of a single dose of ChAdOx1 vaccine at 16 weeks post-vaccination in a sample of healthy and young participants.

Design: Cross-sectional study SETTING: Academic teaching hospital in Riyadh, Saudi Arabia SUBJECTS AND METHODS: Healthy participants 18-50 years of age, who received one dose of ChAdOx1 vaccine and had no history of SARS CoV-2 infection were recruited, and blood samples were obtained 16 weeks after vaccination to assess immunogenicity using a commercially available kit.

Main outcome measures: The rate of SARS-CoV-2 infection within 16 weeks post-vaccination.

Sample size: 385 participants with median (IQR) age of 34 (29-38) years.

Results: Eleven (2.8%) participants acquired polymerase chain reaction (PCR)-confirmed infection within 16 weeks after a single dose of ChAdOx1 vaccine (mean [SD] 42.5 [28] days post-vaccination). No hospital or intensive care unit admissions occurred among the subjects in this sample. Females were significantly over-represented in PCR-confirmed cases of SARS-CoV-2 infection, with 10 of 11 infections occurring in females (P=.006). Antibody response against anti-spike IgG were detectable in 92.7% of subjects at 16 weeks' post-vaccination. The median anti-spike IgG level after vaccination was 273.1 (IQR 107-1052 AU/mL). However, the anti-nucleocapsid IgG antibody demonstrated a sensitivity of only 20%.

Conclusion: A single dose of ChAdOx1 vaccine in healthy and young individuals was associated with a low, single-digit rate of PCR-confirmed infection, most of which were mild.

Limitations: Small sample size and single-center.

Conflict of interest: None.

背景:在沙特阿拉伯,年轻健康参与者接种16周后单剂量ChAdOx1疫苗的严重急性呼吸综合征冠状病毒2 (SARS CoV-2)感染率和免疫原性尚不清楚。目的:评估健康和年轻参与者接种后16周单剂量ChAdOx1疫苗的后续感染率和免疫原性。设计:横断研究环境:沙特阿拉伯利雅得的学术教学医院受试者和方法:招募18-50岁的健康参与者,他们接种了一剂ChAdOx1疫苗,没有SARS CoV-2感染史,接种后16周采集血液样本,使用市售试剂盒评估免疫原性。主要观察指标:接种疫苗后16周内SARS-CoV-2感染率。样本量:385名参与者,中位(IQR)年龄为34岁(29-38岁)。结果:11名(2.8%)参与者在单次接种ChAdOx1疫苗后16周内获得聚合酶链反应(PCR)确诊感染(接种后平均[SD] 42.5[28]天)。本样本的受试者中没有发生住院或重症监护病房的情况。在pcr确诊的SARS-CoV-2感染病例中,女性的比例明显过高,11例感染中有10例为女性(P= 0.006)。在接种疫苗16周后,92.7%的受试者检测到抗刺突IgG抗体应答。接种后抗刺突IgG水平中位数为273.1 (IQR为107 ~ 1052 AU/mL)。而抗核衣壳IgG抗体的敏感性仅为20%。结论:健康和年轻个体单剂量ChAdOx1疫苗与pcr确认的低个位数感染率相关,其中大多数是轻微的。局限性:样本量小,单中心。利益冲突:无。
{"title":"Outcome after single dose of ChAdOx1 vaccine against SARS-CoV-2 infection at 16 weeks post-vaccination among healthy adults in Saudi Arabia.","authors":"Ahlam Alghamdi,&nbsp;Nasser Alsanea,&nbsp;Mohammed Alraey,&nbsp;Mercy Joseph,&nbsp;Mohammed Aboud,&nbsp;Thamer Almangour,&nbsp;Wasaef Alharbi,&nbsp;Hind Alhumidan,&nbsp;Abdalrhman Alanizi,&nbsp;Ahmed Al-Jedai","doi":"10.5144/0256-4947.2022.223","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.223","url":null,"abstract":"<p><strong>Background: </strong>The rate of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infection and immunogenicity of a single dose of ChAdOx1 vaccine at 16 weeks post-vaccination among young and healthy participants remains unclear in Saudi Arabia.</p><p><strong>Objectives: </strong>Assess the rate of subsequent infection and immunogenicity of a single dose of ChAdOx1 vaccine at 16 weeks post-vaccination in a sample of healthy and young participants.</p><p><strong>Design: </strong>Cross-sectional study SETTING: Academic teaching hospital in Riyadh, Saudi Arabia SUBJECTS AND METHODS: Healthy participants 18-50 years of age, who received one dose of ChAdOx1 vaccine and had no history of SARS CoV-2 infection were recruited, and blood samples were obtained 16 weeks after vaccination to assess immunogenicity using a commercially available kit.</p><p><strong>Main outcome measures: </strong>The rate of SARS-CoV-2 infection within 16 weeks post-vaccination.</p><p><strong>Sample size: </strong>385 participants with median (IQR) age of 34 (29-38) years.</p><p><strong>Results: </strong>Eleven (2.8%) participants acquired polymerase chain reaction (PCR)-confirmed infection within 16 weeks after a single dose of ChAdOx1 vaccine (mean [SD] 42.5 [28] days post-vaccination). No hospital or intensive care unit admissions occurred among the subjects in this sample. Females were significantly over-represented in PCR-confirmed cases of SARS-CoV-2 infection, with 10 of 11 infections occurring in females (<i>P</i>=.006). Antibody response against anti-spike IgG were detectable in 92.7% of subjects at 16 weeks' post-vaccination. The median anti-spike IgG level after vaccination was 273.1 (IQR 107-1052 AU/mL). However, the anti-nucleocapsid IgG antibody demonstrated a sensitivity of only 20%.</p><p><strong>Conclusion: </strong>A single dose of ChAdOx1 vaccine in healthy and young individuals was associated with a low, single-digit rate of PCR-confirmed infection, most of which were mild.</p><p><strong>Limitations: </strong>Small sample size and single-center.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":" ","pages":"223-228"},"PeriodicalIF":1.6,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/be/55/0256-4947.2022.223.PMC9357300.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40686128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health outcomes after acute ischemic stroke:retrospective and survival analysis from Oman. 急性缺血性卒中后的健康结果:来自阿曼的回顾性和生存分析
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-07-01 Epub Date: 2022-08-04 DOI: 10.5144/0256-4947.2022.269
Abdullah M Al Alawi, Ikhlas Al Busaidi, Emaad Al Shibli, Al-Reem Al-Senaidi, Shahd Al Manwari, Ibtisam Al Busaidi, Fatema Muhanna, Ahmed Al Qassabi

Background: Stroke mortality and related functional disability have been declining over the last two decades, but stroke continues to represent the second leading cause of cardiovascular death worldwide and the number one cause for acquired long-term disability.

Objectives: Assess short- and long-term health outcomes after acute ischemic stroke and analyze factors associated with poor survival and functional outcomes.

Design: Retrospective and survival analysis SETTING: Inpatient unit at a tertiary care referral hospital.

Patients and methods: All patients admitted with acute ischemic stroke from 1 January 2017 to 31 August 2018 were included in the study. Functional status was assessed using the modified Rankin Scale (mRS). Other demographic and clinical variables were obtained from medical records. Data were analyzed by multivariable logistic regression, Cox proportional hazards, and the Kaplan-Meier method. Long-term follow-up data, including mortality and mRS was collected by follow-up phone call.

Main outcome measures: Functional dependency and factors associated with mortality.

Sample size and characteristics: 110 with mean age of 67.0 (14.7) years; 59 patients (53.6%) were males.

Results: Hypertension (75.5%), diabetes mellitus (54.6%), and dyslipidemia (29.1%) were common. Sixty-five patients (59.1%) had mRS >2 upon discharge including 18 patients (16.4%) who died during the hospital stay. The cumulative mortality rate was 25.4% (28/110) at 12 months and 30.0% (33/110) at 24 months. Twenty-nine stroke survivors (29/70, 41.4%) remained physically dependent (mRS >2) at the end of follow-up. Old age, atrial fibrillation, history of prior stroke, chronic kidney disease, and peripheral arterial disease were associated with increased mortality and functional dependence.

Conclusions: Patients in Oman with acute ischemic stroke tend to have a high comorbidity burden, and their functional dependency and mortality are higher compared to patients from developed countries. Therefore, evidence-based measures such as establishing stroke units are essential to improve the health outcomes of patients with acute ischemic stroke.

Limitations: Retrospective at single center.

Conflict of interest: None.

背景:在过去的二十年中,卒中死亡率和相关的功能残疾一直在下降,但卒中仍然是世界范围内心血管死亡的第二大原因,也是获得性长期残疾的第一大原因。目的:评估急性缺血性卒中后的短期和长期健康结果,并分析与生存不良和功能预后相关的因素。设计:回顾性和生存分析设置:一家三级转诊医院的住院病房。患者和方法:2017年1月1日至2018年8月31日入院的所有急性缺血性脑卒中患者纳入研究。采用改良Rankin量表(mRS)评估功能状态。其他人口统计学和临床变量从医疗记录中获得。采用多变量logistic回归、Cox比例风险和Kaplan-Meier法对数据进行分析。通过随访电话收集长期随访数据,包括死亡率和mRS。主要结局指标:功能依赖和与死亡率相关的因素。样本量和特征:110例,平均年龄67.0(14.7)岁;男性59例(53.6%)。结果:高血压(75.5%)、糖尿病(54.6%)、血脂异常(29.1%)较为常见。出院时mRS >2者65例(59.1%),其中住院期间死亡18例(16.4%)。12个月的累计死亡率为25.4%(28/110),24个月的累计死亡率为30.0%(33/110)。29名脑卒中幸存者(29/70,41.4%)在随访结束时仍有身体依赖(mRS >2)。老年、房颤、既往卒中史、慢性肾脏疾病和外周动脉疾病与死亡率和功能依赖增加相关。结论:阿曼急性缺血性脑卒中患者往往有较高的合并症负担,其功能依赖性和死亡率高于发达国家患者。因此,建立卒中单元等循证措施对于改善急性缺血性卒中患者的健康结果至关重要。局限性:单中心回顾性研究。利益冲突:无。
{"title":"Health outcomes after acute ischemic stroke:retrospective and survival analysis from Oman.","authors":"Abdullah M Al Alawi,&nbsp;Ikhlas Al Busaidi,&nbsp;Emaad Al Shibli,&nbsp;Al-Reem Al-Senaidi,&nbsp;Shahd Al Manwari,&nbsp;Ibtisam Al Busaidi,&nbsp;Fatema Muhanna,&nbsp;Ahmed Al Qassabi","doi":"10.5144/0256-4947.2022.269","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.269","url":null,"abstract":"<p><strong>Background: </strong>Stroke mortality and related functional disability have been declining over the last two decades, but stroke continues to represent the second leading cause of cardiovascular death worldwide and the number one cause for acquired long-term disability.</p><p><strong>Objectives: </strong>Assess short- and long-term health outcomes after acute ischemic stroke and analyze factors associated with poor survival and functional outcomes.</p><p><strong>Design: </strong>Retrospective and survival analysis SETTING: Inpatient unit at a tertiary care referral hospital.</p><p><strong>Patients and methods: </strong>All patients admitted with acute ischemic stroke from 1 January 2017 to 31 August 2018 were included in the study. Functional status was assessed using the modified Rankin Scale (mRS). Other demographic and clinical variables were obtained from medical records. Data were analyzed by multivariable logistic regression, Cox proportional hazards, and the Kaplan-Meier method. Long-term follow-up data, including mortality and mRS was collected by follow-up phone call.</p><p><strong>Main outcome measures: </strong>Functional dependency and factors associated with mortality.</p><p><strong>Sample size and characteristics: </strong>110 with mean age of 67.0 (14.7) years; 59 patients (53.6%) were males.</p><p><strong>Results: </strong>Hypertension (75.5%), diabetes mellitus (54.6%), and dyslipidemia (29.1%) were common. Sixty-five patients (59.1%) had mRS >2 upon discharge including 18 patients (16.4%) who died during the hospital stay. The cumulative mortality rate was 25.4% (28/110) at 12 months and 30.0% (33/110) at 24 months. Twenty-nine stroke survivors (29/70, 41.4%) remained physically dependent (mRS >2) at the end of follow-up. Old age, atrial fibrillation, history of prior stroke, chronic kidney disease, and peripheral arterial disease were associated with increased mortality and functional dependence.</p><p><strong>Conclusions: </strong>Patients in Oman with acute ischemic stroke tend to have a high comorbidity burden, and their functional dependency and mortality are higher compared to patients from developed countries. Therefore, evidence-based measures such as establishing stroke units are essential to improve the health outcomes of patients with acute ischemic stroke.</p><p><strong>Limitations: </strong>Retrospective at single center.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":" ","pages":"269-275"},"PeriodicalIF":1.6,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/64/c3/0256-4947.2022.269.PMC9357299.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40685670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Clinical outcomes of patients with COVID-19 and inflammatory rheumatic diseases receiving biological/targeted therapy 新冠肺炎和炎性风湿性疾病患者接受生物/靶向治疗的临床结果
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-05-01 DOI: 10.5144/0256-4947.2022.155
Ö. Pehlivan, Tutku Aydin
BACKGROUND: Anti-cytokine treatments are used in the treatment of severe COVID-19. Other studies have shown statistical significance with TNF inhibitors but not with other biological/targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARD). OBJECTIVES: Compare the rate of severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) infection and the course and incidence of COVID-19 infection in patients who received b/tsDMARD with control patients. DESIGN: Analytical cross-sectional SETTINGS: Tertiary care hospital PATIENTS AND METHODS: All patients who applied to the rheumatology outpatient clinic between June 2020-March 2021 and received b/tsDMARD were included in the study. All patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis who applied to the rheumatology outpatient clinic in the three months before March 2021 and did not receive b/tsDMARD were included as the control group. History of COVID-19 infection and treatments were recorded. Multivariate analysis was performed to assess factors associated with use of tumor necrosis factor (TNF) inhibitors and differences between specific biologic drugs. MAIN OUTCOME MEASURES: Rate of COVID-19 disease among patients using biological/targeted synthetic therapy and non-biological/targeted synthetic therapy. COVID-19 clinical outcomes (hospitalization, intensive care admission, mechanical ventilation and death). SAMPLE SIZE: 553 in total; 341 received b/tsDMARD, 212 in the control group that did not receive b/tsDMARD. RESULTS: One hundred patients (18%) had been infected with SARS-COV-2. The difference in SARS-COV-2 infection between b/tsDMARD and the control was statistically significant (13, 2% vs. 25, 9%, respectively) (P<.001). The hospital stays were longer in the controls (P<.001). Multinomial regression analysis revealed that COVID-19 negative patients were more likely to use tumor necrosis factor (TNF) inhibitors (OR: 2, 911; 95% CI: 1.727-4.908; P<.001) compared to COVID-19 positive participants. Multinomial logistic regression analysis indicated that non-hospitalized patients were more likely to use TNF inhibitors (OR: 11, 006; 95% CI: 3.447-35.138; P<.001) and there was no significant difference between b/tsDMARDs other than TNF inhibitors in frequency of hospitalization. CONCLUSIONS: Patients who were medicated with b/tsDMARD were less likely to be infected with COVID-19 and be hospitalized due to the infection. We have found that this effect was particularly dependent on the use of TNF inhibitors. LIMITATIONS: Conducted in a single center and unable to provide a homogeneous study population. CONFLICT OF INTEREST: None.
背景:抗细胞因子治疗用于治疗严重的新冠肺炎。其他研究表明,TNF抑制剂具有统计学意义,但与其他生物/靶向合成疾病修饰抗风湿药物(b/tsDMARD)没有统计学意义。目的:比较接受b/tsDMARD的患者与对照患者的严重急性呼吸综合征冠状病毒-2(SARS-COV-2)感染率、新冠肺炎感染的病程和发病率。设计:分析横断面设置:三级护理医院患者和方法:所有在2020年6月至2021年3月期间申请风湿病门诊并接受b/tsDMARD的患者均纳入研究。所有在2021年3月之前的三个月内申请风湿病门诊且未接受b/tsDMARD治疗的类风湿性关节炎、银屑病关节炎和脊椎关节炎患者均被纳入对照组。记录新冠肺炎感染史和治疗情况。进行多因素分析以评估与肿瘤坏死因子(TNF)抑制剂的使用相关的因素以及特定生物药物之间的差异。主要观察指标:使用生物/靶向合成治疗和非生物/靶向合成治疗的新冠肺炎患者患病率。新冠肺炎临床结果(住院、重症监护入院、机械通气和死亡)。样本量:共553个;未接收b/tsDMARD的对照组中的341、212接收b/tsDMA RD。结果:100名患者(18%)感染了严重急性呼吸系统综合征冠状病毒2型。b/tsDMARD与对照组之间的SARS-COV-2感染差异具有统计学意义(分别为13%、2%和25%、9%)(P<.001)。对照组的住院时间更长(P<0.001)。多项回归分析显示,与对照组相比,新冠肺炎阴性患者更可能使用肿瘤坏死因子(TNF)抑制剂(OR:2911;95%CI:1.727-4.908;P<.001新冠肺炎阳性参与者。多项逻辑回归分析表明,非住院患者更有可能使用TNF抑制剂(OR:11006;95%CI:3.447-35.138;P<.001),除TNF抑制剂外,b/tsDMARD之间的住院频率没有显著差异。结论:服用b/tsDMARD的患者感染新冠肺炎和因感染住院的可能性较低。我们发现这种作用特别依赖于TNF抑制剂的使用。局限性:在单一中心进行,无法提供同质的研究人群。利益冲突:无。
{"title":"Clinical outcomes of patients with COVID-19 and inflammatory rheumatic diseases receiving biological/targeted therapy","authors":"Ö. Pehlivan, Tutku Aydin","doi":"10.5144/0256-4947.2022.155","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.155","url":null,"abstract":"BACKGROUND: Anti-cytokine treatments are used in the treatment of severe COVID-19. Other studies have shown statistical significance with TNF inhibitors but not with other biological/targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARD). OBJECTIVES: Compare the rate of severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) infection and the course and incidence of COVID-19 infection in patients who received b/tsDMARD with control patients. DESIGN: Analytical cross-sectional SETTINGS: Tertiary care hospital PATIENTS AND METHODS: All patients who applied to the rheumatology outpatient clinic between June 2020-March 2021 and received b/tsDMARD were included in the study. All patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis who applied to the rheumatology outpatient clinic in the three months before March 2021 and did not receive b/tsDMARD were included as the control group. History of COVID-19 infection and treatments were recorded. Multivariate analysis was performed to assess factors associated with use of tumor necrosis factor (TNF) inhibitors and differences between specific biologic drugs. MAIN OUTCOME MEASURES: Rate of COVID-19 disease among patients using biological/targeted synthetic therapy and non-biological/targeted synthetic therapy. COVID-19 clinical outcomes (hospitalization, intensive care admission, mechanical ventilation and death). SAMPLE SIZE: 553 in total; 341 received b/tsDMARD, 212 in the control group that did not receive b/tsDMARD. RESULTS: One hundred patients (18%) had been infected with SARS-COV-2. The difference in SARS-COV-2 infection between b/tsDMARD and the control was statistically significant (13, 2% vs. 25, 9%, respectively) (P<.001). The hospital stays were longer in the controls (P<.001). Multinomial regression analysis revealed that COVID-19 negative patients were more likely to use tumor necrosis factor (TNF) inhibitors (OR: 2, 911; 95% CI: 1.727-4.908; P<.001) compared to COVID-19 positive participants. Multinomial logistic regression analysis indicated that non-hospitalized patients were more likely to use TNF inhibitors (OR: 11, 006; 95% CI: 3.447-35.138; P<.001) and there was no significant difference between b/tsDMARDs other than TNF inhibitors in frequency of hospitalization. CONCLUSIONS: Patients who were medicated with b/tsDMARD were less likely to be infected with COVID-19 and be hospitalized due to the infection. We have found that this effect was particularly dependent on the use of TNF inhibitors. LIMITATIONS: Conducted in a single center and unable to provide a homogeneous study population. CONFLICT OF INTEREST: None.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"155 - 164"},"PeriodicalIF":1.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42655326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Histopathological pattern of endometrial biopsies in patients with abnormal uterine bleeding in a tertiary referral hospital in Jordan 在约旦三级转诊医院异常子宫出血患者子宫内膜活检的组织病理学模式
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-05-01 DOI: 10.5144/0256-4947.2022.204
E. Alshdaifat, Sami Saif El-Deen Al-Horani, M. Al-Sous, S. Al-Horani, Fernas Emile Sahawneh, A. Sindiani
BACKGROUND: Abnormal uterine bleeding (AUB) is a symptom that deviates from the normal menstrual cycle. AUB is characterized by changes in the frequency, volume, and duration of the menstrual flow. The etiology of AUB, which varies with age, may be attributed to both structural and non-structural causes. OBJECTIVES: Determine the histopathological pattern of endometrial biopsies in patients with AUB across different age and parity groups who have undergone dilation and curettage (D&C), along with the discrepancy between D&C and histopathological findings after hysterectomy. DESIGN: Retrospective chart review SETTING: Tertiary referral hospital PATIENTS AND METHODS: We collected data on all patients diagnosed with AUB between January 2015 and December 2020. Histopathological findings of all D&C endometrial biopsy samples were examined after being categorized by age and parity groups. Sensitivity, specificity, positive predictive value, and NPV were calculated to evaluate the diagnostic accuracy of D&C. MAIN OUTCOME MEASURES: Histopathological pattern of D&C endometrial biopsies by age and parity groups. SAMPLE SIZE: 3233 patients. RESULTS: Most patients were in the 18-39 year age group, with normal cyclical findings being the most common histopathological finding. Malignant lesions were observed in 42 patients with a majority being older than 50 years. In 13.3% (42/316) of patients, D&C failed to detect intrauterine disorder that was found on hysterectomy. The overall accuracy of D&C in determining the existence of normal versus pathological findings was 75.60%, the sensitivity was 72.90%, the specificity was 77.90%, the positive predictive value was 73.86% and the NPV was 77.05% in our patients. CONCLUSION: Normal cyclic changes account for the highest proportion of histopathological findings. However, hyperplasia and malignancies are important causes of perimenopausal and postmenopausal bleeding. While the use of D&C as a sampling tool for AUB cases remains questionable, the use of D&C in diagnosing premalignant and malignant cases is highly effective. LIMITATIONS: Single-center, retrospective design, incomplete medical records, and inter-rater reliability could not be determined. CONFLICT OF INTEREST: None.
背景:异常子宫出血(AUB)是一种偏离正常月经周期的症状。AUB的特征是月经流量的频率、体积和持续时间的变化。AUB的病因因年龄而异,可归因于结构性和非结构性原因。目的:确定不同年龄组和产次组接受扩张刮除术(D&C)的AUB患者子宫内膜活检的组织病理学模式,以及子宫切除术后D&C和组织病理学结果之间的差异。设计:回顾性图表回顾设置:三级转诊医院患者和方法:我们收集了2015年1月至2020年12月期间所有诊断为AUB的患者的数据。根据年龄组和产次组对所有D&C子宫内膜活检样本进行组织病理学检查。计算敏感性、特异性、阳性预测值和NPV来评估D&C的诊断准确性。主要观察指标:按年龄和产次分组的D&C子宫内膜活检的组织病理学模式。样本量:3233名患者。结果:大多数患者年龄在18-39岁,正常周期性表现是最常见的组织病理学表现。在42名患者中观察到恶性病变,其中大多数患者年龄在50岁以上。在13.3%(42/316)的患者中,D&C未能发现子宫切除术中发现的宫内疾病。在我们的患者中,D&C在确定是否存在正常与病理结果方面的总体准确率为75.60%,敏感性为72.90%,特异性为77.90%,阳性预测值为73.86%,NPV为77.05%。结论:正常周期性变化在组织病理学表现中所占比例最高。然而,增生和恶性肿瘤是围绝经期和绝经后出血的重要原因。虽然使用D&C作为AUB病例的采样工具仍然值得怀疑,但使用D&C诊断癌前和恶性病例是非常有效的。局限性:无法确定单中心、回顾性设计、不完整的医疗记录和评分者间的可靠性。利益冲突:无。
{"title":"Histopathological pattern of endometrial biopsies in patients with abnormal uterine bleeding in a tertiary referral hospital in Jordan","authors":"E. Alshdaifat, Sami Saif El-Deen Al-Horani, M. Al-Sous, S. Al-Horani, Fernas Emile Sahawneh, A. Sindiani","doi":"10.5144/0256-4947.2022.204","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.204","url":null,"abstract":"BACKGROUND: Abnormal uterine bleeding (AUB) is a symptom that deviates from the normal menstrual cycle. AUB is characterized by changes in the frequency, volume, and duration of the menstrual flow. The etiology of AUB, which varies with age, may be attributed to both structural and non-structural causes. OBJECTIVES: Determine the histopathological pattern of endometrial biopsies in patients with AUB across different age and parity groups who have undergone dilation and curettage (D&C), along with the discrepancy between D&C and histopathological findings after hysterectomy. DESIGN: Retrospective chart review SETTING: Tertiary referral hospital PATIENTS AND METHODS: We collected data on all patients diagnosed with AUB between January 2015 and December 2020. Histopathological findings of all D&C endometrial biopsy samples were examined after being categorized by age and parity groups. Sensitivity, specificity, positive predictive value, and NPV were calculated to evaluate the diagnostic accuracy of D&C. MAIN OUTCOME MEASURES: Histopathological pattern of D&C endometrial biopsies by age and parity groups. SAMPLE SIZE: 3233 patients. RESULTS: Most patients were in the 18-39 year age group, with normal cyclical findings being the most common histopathological finding. Malignant lesions were observed in 42 patients with a majority being older than 50 years. In 13.3% (42/316) of patients, D&C failed to detect intrauterine disorder that was found on hysterectomy. The overall accuracy of D&C in determining the existence of normal versus pathological findings was 75.60%, the sensitivity was 72.90%, the specificity was 77.90%, the positive predictive value was 73.86% and the NPV was 77.05% in our patients. CONCLUSION: Normal cyclic changes account for the highest proportion of histopathological findings. However, hyperplasia and malignancies are important causes of perimenopausal and postmenopausal bleeding. While the use of D&C as a sampling tool for AUB cases remains questionable, the use of D&C in diagnosing premalignant and malignant cases is highly effective. LIMITATIONS: Single-center, retrospective design, incomplete medical records, and inter-rater reliability could not be determined. CONFLICT OF INTEREST: None.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"204 - 213"},"PeriodicalIF":1.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49098111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Spinal anesthesia versus combined sciatic nerve/lumbar plexus nerve block in elderly patients undergoing total hip arthroplasty: a retrospective study. 脊柱麻醉对老年全髋关节置换术患者坐骨神经/腰丛神经联合阻滞的影响:一项回顾性研究。
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-05-01 Epub Date: 2022-06-02 DOI: 10.5144/0256-4947.2022.174
Mustafa Kaçmaz, Zeynep Yuksel Turhan

Background: The most important cause of mortality due to long bone fractures in the elderly patients are femoral fractures that require total hip arthroplasty (THA). THA surgeries may cause severe postoperative pain, long hospital stays, a need for transfusion and mortality.

Objective: Compare outcomes of spinal anesthesia (SA) versus combined sciatic nerve/lumbar plexus block (CSLPB).

Design: Retrospective cohort trıal.

Setting: University hospital in Turkey.

Patients and methods: We selected patients from the electronic medical records by date of surgery (most recent first) and compared demographic and pre- and postoperative clinical characteristics including the amount of opioid use within the first 48 postoperative hours, 30-day mortality rates, length of hospital stay, intraoperative oxygen saturation (SpO2) and mean arterial pressure (MAP) values, duration of the surgery, and blood transfusion need.

Main outcome measure: Opioid use within the first 48 postoperative hours.

Sample size: 204, 102 patients in each group with overall median (IQR) age of 82 (10.2) years.

Results: There was no significant difference between the groups in terms of the amount of opioid use within the postoperative 48 hours, 30-day mortality rates, intensive care need, duration of the surgery, blood transfusion need, and length of hospital stay. While the intraoperative SpO2 value was lower in the CSLPB group (P=.03), MAP values were lower in the SA group (P=.046). Preoperative American Society of Anesthesiology score (ASA) scores (P=.039) and the number of comorbidities were higher in the CSLPB group.

Conclusion: We prefer CSLPB used with standardized sedation protocols for anesthesia in THA surgery in elderly patients.

Limitations: Retrospective design and single-centered.

Conflict of interest: None.

背景:老年患者长骨骨折死亡的最重要原因是股骨骨折需要全髋关节置换术(THA)。THA手术可能导致严重的术后疼痛、长时间住院、需要输血和死亡。目的:比较脊髓麻醉(SA)与坐骨神经/腰丛神经联合阻滞(CSLPB)的效果。设计:回顾性队列trıal。地点:土耳其大学医院。患者和方法:我们根据手术日期(最近一次)从电子病历中选择患者,并比较人口统计学和术前和术后临床特征,包括术后前48小时内阿片类药物的使用量、30天死亡率、住院时间、术中氧饱和度(SpO2)和平均动脉压(MAP)值、手术持续时间和输血需求。主要结局指标:术后48小时内阿片类药物使用情况。样本量:每组204,102例患者,总中位(IQR)年龄为82(10.2)岁。结果:两组在术后48小时内阿片类药物使用量、30天死亡率、重症监护需求、手术时间、输血需求和住院时间方面无显著差异。CSLPB组术中SpO2值较低(P= 0.03), SA组术中MAP值较低(P= 0.046)。CSLPB组术前美国麻醉学会评分(ASA)评分(P= 0.039)及共病数较高。结论:在老年THA手术中,我们更倾向于采用CSLPB配合标准化镇静方案进行麻醉。局限性:回顾性设计和单一中心。利益冲突:无。
{"title":"Spinal anesthesia versus combined sciatic nerve/lumbar plexus nerve block in elderly patients undergoing total hip arthroplasty: a retrospective study.","authors":"Mustafa Kaçmaz,&nbsp;Zeynep Yuksel Turhan","doi":"10.5144/0256-4947.2022.174","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.174","url":null,"abstract":"<p><strong>Background: </strong>The most important cause of mortality due to long bone fractures in the elderly patients are femoral fractures that require total hip arthroplasty (THA). THA surgeries may cause severe postoperative pain, long hospital stays, a need for transfusion and mortality.</p><p><strong>Objective: </strong>Compare outcomes of spinal anesthesia (SA) versus combined sciatic nerve/lumbar plexus block (CSLPB).</p><p><strong>Design: </strong>Retrospective cohort trıal.</p><p><strong>Setting: </strong>University hospital in Turkey.</p><p><strong>Patients and methods: </strong>We selected patients from the electronic medical records by date of surgery (most recent first) and compared demographic and pre- and postoperative clinical characteristics including the amount of opioid use within the first 48 postoperative hours, 30-day mortality rates, length of hospital stay, intraoperative oxygen saturation (SpO<sub>2</sub>) and mean arterial pressure (MAP) values, duration of the surgery, and blood transfusion need.</p><p><strong>Main outcome measure: </strong>Opioid use within the first 48 postoperative hours.</p><p><strong>Sample size: </strong>204, 102 patients in each group with overall median (IQR) age of 82 (10.2) years.</p><p><strong>Results: </strong>There was no significant difference between the groups in terms of the amount of opioid use within the postoperative 48 hours, 30-day mortality rates, intensive care need, duration of the surgery, blood transfusion need, and length of hospital stay. While the intraoperative SpO<sub>2</sub> value was lower in the CSLPB group (<i>P</i>=.03), MAP values were lower in the SA group (<i>P</i>=.046). Preoperative American Society of Anesthesiology score (ASA) scores (<i>P</i>=.039) and the number of comorbidities were higher in the CSLPB group.</p><p><strong>Conclusion: </strong>We prefer CSLPB used with standardized sedation protocols for anesthesia in THA surgery in elderly patients.</p><p><strong>Limitations: </strong>Retrospective design and single-centered.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":" ","pages":"174-180"},"PeriodicalIF":1.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c8/7c/0256-4947.2022.174.PMC9167455.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40406836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hematologic reference intervals for healthy adult Saudis in Riyadh 利雅得健康成年沙特人的血液学参考区间
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-05-01 DOI: 10.5144/0256-4947.2022.191
Salwa Bakr, A. Alfattani, R. Al-Nounou, N. Bakshi, H. Khogeer, Maha Alharbi, Nasser Almousa, Waleed S. Alomaim, Amelita M Aguilos, May Almashary, T. Owaidah
BACKGROUND: Laboratory hematological tests are widely used in clinical practice to assess health and disease conditions. Reference ranges provided by laboratory reports are considered the most authoritative medical tools to assist in the decision-making phase. International standards institutes recommend that reference ranges be established for each region. OBJECTIVES: Provide reference values of routine hematological parameters in Saudi adults according to age and gender. DESIGN: Cross-sectional SETTING: Central province of Saudi Arabia. PATIENTS AND METHODS: Apparently healthy Saudi adults were subjected to laboratory testing of routine hematological parameters (full blood count, hemostatic profile, and serum hematinics), after completing a detailed health medical questionnaire. MAIN OUTCOME MEASURES: Hematological reference values based on the local population. SAMPLE SIZE AND CHARACTERISTICS: 637 after screening 827 potentially healthy Saudi adults with ages ranging from 15 to 65 years. RESULTS: The reference values of routine hematological parameters for the full population and by gender are presented with 90% CI as the lower and upper limits. Reference ranges mostly differed from universal established ranges shown in textbooks. CONCLUSION: The reference ranges of routine hematologic parameters for accurate assessment and appropriate management will help improve the routine clinical care of the adult Saudi population. LIMITATIONS: Difficulty in assessing health status of participants, who could have subclinical illnesses not reflected in the evaluated blood measurement. Lack of ability to eliminate individuals who might be carriers for haemoglobinopathies. Studies with larger sample sizes from different areas of the country are required to achieve a more accurate representation of the whole Saudi population. CONFLICT OF INTEREST: None.
背景:实验室血液学检查在临床实践中广泛用于评估健康和疾病状况。实验室报告提供的参考范围被认为是帮助决策阶段的最权威的医疗工具。国际标准协会建议为每个地区建立参考范围。目的:根据年龄和性别提供沙特成年人常规血液学参数的参考值。设计:横断面背景:沙特阿拉伯中部省份。患者和方法:在完成一份详细的健康医学问卷后,对看似健康的沙特成年人进行常规血液学参数(全血计数、止血谱和血清血液学)的实验室测试。主要观察指标:基于当地人群的血液学参考值。样本量和特征:筛选827名年龄在15至65岁之间的潜在健康沙特成年人后,共637人。结果:全人群和按性别划分的常规血液学参数参考值以90%CI为下限和上限。参考范围大多不同于教科书中所示的通用既定范围。结论:常规血液学参数的参考范围有助于准确评估和适当管理,这将有助于改善沙特成年人群的常规临床护理。局限性:难以评估参与者的健康状况,他们可能患有未反映在评估的血液测量中的亚临床疾病。缺乏消除可能是血红蛋白病携带者的能力。需要对来自该国不同地区的较大样本量进行研究,以更准确地代表整个沙特人口。利益冲突:无。
{"title":"Hematologic reference intervals for healthy adult Saudis in Riyadh","authors":"Salwa Bakr, A. Alfattani, R. Al-Nounou, N. Bakshi, H. Khogeer, Maha Alharbi, Nasser Almousa, Waleed S. Alomaim, Amelita M Aguilos, May Almashary, T. Owaidah","doi":"10.5144/0256-4947.2022.191","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.191","url":null,"abstract":"BACKGROUND: Laboratory hematological tests are widely used in clinical practice to assess health and disease conditions. Reference ranges provided by laboratory reports are considered the most authoritative medical tools to assist in the decision-making phase. International standards institutes recommend that reference ranges be established for each region. OBJECTIVES: Provide reference values of routine hematological parameters in Saudi adults according to age and gender. DESIGN: Cross-sectional SETTING: Central province of Saudi Arabia. PATIENTS AND METHODS: Apparently healthy Saudi adults were subjected to laboratory testing of routine hematological parameters (full blood count, hemostatic profile, and serum hematinics), after completing a detailed health medical questionnaire. MAIN OUTCOME MEASURES: Hematological reference values based on the local population. SAMPLE SIZE AND CHARACTERISTICS: 637 after screening 827 potentially healthy Saudi adults with ages ranging from 15 to 65 years. RESULTS: The reference values of routine hematological parameters for the full population and by gender are presented with 90% CI as the lower and upper limits. Reference ranges mostly differed from universal established ranges shown in textbooks. CONCLUSION: The reference ranges of routine hematologic parameters for accurate assessment and appropriate management will help improve the routine clinical care of the adult Saudi population. LIMITATIONS: Difficulty in assessing health status of participants, who could have subclinical illnesses not reflected in the evaluated blood measurement. Lack of ability to eliminate individuals who might be carriers for haemoglobinopathies. Studies with larger sample sizes from different areas of the country are required to achieve a more accurate representation of the whole Saudi population. CONFLICT OF INTEREST: None.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"191 - 203"},"PeriodicalIF":1.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48200710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Annals of Saudi Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1